ClinicalTrials.govpublic full text
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
rectal cancer, rectal adenocarcinoma, rectal cancer, radiotherapy, rectal cancer patients, immunotherapy, total neoadjuvant therapy, total neoadjuvant treatment, targeted therapy, chemoradiotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832936
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.